DaVita
DVA
#1883
Rank
A$16.08 B
Marketcap
A$252.07
Share price
1.01%
Change (1 day)
20.44%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): A$16.39

According to DaVita's latest financial reports the company's current EPS (TTM) is A$15.35. In 2025 the company made an earnings per share (EPS) of A$14.12 a decrease over its 2024 EPS that were of A$15.39.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$16.3916.12%
2025A$14.12-8.25%
2024A$15.3944.94%
2023A$10.6227.26%
2022A$8.34-35.56%
2021A$12.9544.1%
2020A$8.9819.7%
2019A$7.51540.48%
2018A$1.17-76.07%
2017A$4.90-19.31%
2016A$6.07242.52%
2015A$1.77-62.87%
2014A$4.7713.43%
2013A$4.218.45%
2012A$3.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$33.91 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$15.85 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$27.05 76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.89-81.20%๐Ÿ‡บ๐Ÿ‡ธ USA